Page last updated: 2024-08-22

poloxalene and Leukemia, Promyelocytic, Acute

poloxalene has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boucher, KM; Kaur, I; Kern, SE; Kosak, KM; Shami, PJ; Terrazas, M	1

Other Studies

1 other study(ies) available for poloxalene and Leukemia, Promyelocytic, Acute

Article	Year
Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles. The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:9 Topics: Antineoplastic Agents; Azo Compounds; Cell Nucleus; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Micelles; Nitric Oxide; Nitric Oxide Donors; Nuclear Proteins; Piperazines; Poloxalene; Prodrugs; Protein Processing, Post-Translational; Solubility	2013

Article

Year

Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles.

The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:9

Topics: Antineoplastic Agents; Azo Compounds; Cell Nucleus; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Micelles; Nitric Oxide; Nitric Oxide Donors; Nuclear Proteins; Piperazines; Poloxalene; Prodrugs; Protein Processing, Post-Translational; Solubility

2013